Recent News

• 02.26.2026 - BioLife Solutions Reports Fourth Quarter and Full Year 2025 Financial Results from Continuing Operations
• 02.19.2026 - How Early Supplier Partnership Strategies Support Cell Therapy Approvals
• 02.17.2026 - BioLife Solutions to Report Fourth Quarter and Full Year 2025 Financial Results and Business Update on February 26, 2026
• 02.12.2026 - BioLife Solutions Signs Multi-Year Supply Agreement with Qkine Limited to Expand its Product Portfolio into the Rapidly Growing Cytokines Market

Recent Filings

• 02.26.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.26.2026 - 8-K Current report
• 02.26.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.26.2026 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 02.26.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.26.2026 - EX-99.1 EX-99.1
• 02.26.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.26.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.26.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.26.2026 - 4 Statement of changes in beneficial ownership of securities